In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo.
暂无分享,去创建一个
[1] N. Maclaren,et al. The role of tyrosinase in autoimmune vitiligo , 1994, The Lancet.
[2] J. Bystryn,et al. Cytolytic antibodies to melanocytes in vitiligo. , 1993, The Journal of investigative dermatology.
[3] C. Yu,et al. Coexistence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo. , 1993, The Journal of investigative dermatology.
[4] Amos Etzioni,et al. Vitiliginous vs pigmented skin response to intradermal administration of interferon gamma. , 1993, Archives of dermatology.
[5] J. Bystryn,et al. Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. , 1991, The Journal of investigative dermatology.
[6] E. Medrano,et al. Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients. , 1991, The Journal of investigative dermatology.
[7] T. Pillar,et al. Melanocytes and Langerhans cells in aged versus young skin before and after transplantation onto nude mice. , 1991, The Journal of investigative dermatology.
[8] E. Medrano,et al. Successful culture of adult human melanocytes obtained from normal and vitiligo donors. , 1990, The Journal of investigative dermatology.
[9] T. Pillar,et al. Vitiligo and Idiopathic Guttate Hypomelanosis: Repigmentation of Skin Following Engraftment Onto Nude Mice , 1989 .
[10] J. Bystryn,et al. Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity. , 1988, The Journal of investigative dermatology.
[11] G. Naughton,et al. Correlation between vitiligo antibodies and extent of depigmentation in vitiligo. , 1986, Journal of the American Academy of Dermatology.
[12] R. Boissy,et al. A mouse model for vitiligo. , 1986, The Journal of investigative dermatology.
[13] R. Boissy,et al. Delayed-amelanotic (DAM or Smyth) chicken: melanocyte dysfunction in vivo and in vitro. , 1986, The Journal of investigative dermatology.
[14] A. Tosti,et al. Vitiligo and biliary cirrhosis. , 1986, The American journal of gastroenterology.
[15] G. Naughton,et al. Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation. , 1983, The Journal of investigative dermatology.
[16] Diana Brahams,et al. Confidentiality and under-age girls who seek contraceptive advice. , 1983, Lancet.
[17] G. Naughton,et al. Antibodies to normal human melanocytes in vitiligo , 1983, The Journal of experimental medicine.
[18] S. Lamont,et al. Effect of bursectomy on development of a spontaneous postnatal amelanosis. , 1981, Clinical immunology and immunopathology.
[19] J. Voorhees,et al. Pathogenic effects of bullous pemphigoid autoantibodies on rabbit corneal epithelium. , 1981, The Journal of clinical investigation.
[20] T. Miller,et al. The rapid isolation of ribonuclease-free immunoglobulin G by protein A-sepharose affinity chromatography. , 1978, Journal of immunological methods.
[21] A. Peserico,et al. Autoantibodies in vitiligo. , 1976, Archives of dermatology.
[22] H. Katz,et al. Vitiligo and multiple glandular insufficiencies. , 1972, JAMA.
[23] J. Brostoff. Autoantibodies in patients with vitiligo. , 1969, Lancet.
[24] I. Chanarin,et al. VITILIGO AND ITS AETIOLOGICAL RELATIONSHIP TO ORGAN‐SPECIFIC AUTOIMMUNE DISEASE , 1969, The British journal of dermatology.
[25] C. J. Stevenson,et al. VITILIGO, THYROID DISEASE AND AUTOIMMUNITY , 1968, The British journal of dermatology.
[26] O OUCHTERLONY,et al. Diffusion-in-gel methods for immunological analysis. , 1958, Progress in allergy.